An overview of pharmacological activities of acridine derivatives

Magesh M1, Gandhimathi R*2 1Research scholar, Department of Pharmaceutical Chemistry and Analysis, School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Pallavaram, Chennai-600 117, Tamil Nadu, India 2Department of Pharmaceutical Chemistry and Analysis, School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Pallavaram, Chennai-600 117, Tamil Nadu, India


INTRODUCTION
Acridine ( Figure 1) is a versatile heterocyclic nucleus. It was discovered and announced by Graebe and caro in 1870 (Acheson, 1973). Acridine was identi ied as a new basic material in the anthracene fraction of coal tar. Due to it's acrid smell and irritating action on the skin and mucous membrane it was named as acridine subsequently, the different kinds of nomenclature and numbering systems are used (Acheson, 1973). Heterocycle fused acridine possess a variety of biological activities including Ca 2+ releasing, anti-viral, anti-microbial and antitumour properties. Acridine derivatives also act as an enzyme inhibitor and have DNA intercalation and chelating metal properties (Water and Munawar, 1998). When we are looking back history so many acridine derivatives were utilised for various medicinal purposes in different periods. So many novel drug molecules have been developed by modi ication of the acridine nucleus. The molecular modi ication provides so many potent molecules from acridine; for example, bistacrine analogues proved an excellent anti-Alzheimer activity than parent anti-Alzheimer drug tacrine, Acridinones and carboxylates of acridine showed an excellent mosquito larvicidal activity. Analogues of 9-anilino and benzoyl styrene exhibited anti-malarial activity. Braco-19 is a trisubstituted acridine derivative proved a signi icant anti-viral and anti-cancer activity. Benztriazolo acridine derivative showed remarkable antibacterial activity. Derivatives of 9-substituted acridines and polycyclic acridines have signi icant antitubercular activity. Imidaza and thiaza acridine derivatives showed an optimum anti-cancer activity. When thiazolidinedione connected with an ethacridine molecule, it will become a potent anti-fungal agent. Analogues of 9-sulphonamide, 9-anilino and 9-phenoxy acridines produce considerable anti-in lammatory activity. Compounds of 9-anilino acridines and acridinones are considered as potent anti leishmanial agents. In this review, we are aimed to discuss the synthesis and evaluation of respective biological activities of those derivatives of acridines.

Anticholinesterase Activity of Acridine Derivatives
Tacrine was found to be the best lead molecule to improve the intellectual activity of Alzheimer patients. A new series of chiral homo and heterodimers of bis(7)-tacrine synthesised by connecting with heptylene chain as a spacer with a methyl substituent at the C 3 position of the alicyclic region of tacrine nucleus and studied their capability to inhibit acetylcholinesterase and butyrylcholinesterase. It was noted that the R series of homo and hetero dimers with a chlorine atom and S series of dimers without chlorine atom showed the most excellent af inity towards acetyl cholinesterase (Joao et al., 2017).
Di substituted tacrine derivatives were synthesised to discover the novel cholinesterase and carbonic anhydrase inhibitors. It was concluded that the substituted seven-membered heterocycle tacrine analogues selectively showed signi icant inhibitory activity against acetylcholinesterase and butyrylcholinesterases. The cyano at C 6 and C 8 and silyl at C 6 and C 8 and thio methyl at C 6 substituted sevenmembered heterocyclic tacrine showed the best inhibitory activity against acetyl cholinesterases. While methoxy at C 6 Substituted seven-membered heterocycle tacrine showed signi icant inhibitory activity against butyryl cholinesterases (Okten et al., 2019).

Mosquito Larvicidal Activity of Acridine Derivatives
A series of acridinone related compounds were synthesised and characterised by spectral studies then evaluated against the larvas A.aegypti and C.quinquifasciatus. In which the synthesised products were diluted with dechlorinated water and made the solution 2% by Dimethyl sulfoxide. In the larvicidal bioassay ive sets container with 20 numbers larvas of same species mixed with 249 ml of dechlorinated water and 1 ml of test solutions at desired concentrations. Water and dimethyl sulfoxide were taken as a negative control. The number of died larvae was counted after 24 hrs. The same procedure performed in triplicate and the average value considered. The compounds 5a (Figure 2) and 3b ( Figure 3) showed excellent activity against A.aegypti and C.quinquifasciatus respectively (Roopan et al., 2017).
In this study, E-2-benzylidine-7-chloro-9-phenyl-3,4-di hydro acridine-1(2H)-ones synthesised and characterised by FTIR, 1 H and 13 C NMR and ESI-MS spectra. Screened for their larvicidal activity against anopheles stephensi and Hippobosca maculate. Most of the compounds showed good activity against both the larvas (Bharathi et al., 2015). The anti-malarial activity of 9-anilino acridines evaluated by means of targeting an enzyme topoisomerase-II and β-Haematin in malarial parasites.3,6 -Di amino substitution in acridine ring showed considerable improvement in the parasiticidal activity against plasmodium falciparum. Most of the compounds showed remarkable inhibition of β haematin formation. It was thought to be the presence of N, N di methyl amino group in anilino   ring advantageous to this activity. In this study, one another fact was found that the presence of 3,6dichloro analogues are potentiated the β haematin inhibitory effect of acridines than 3,6 -di amino and the mono chloro substituted analogues. It was evidenced by the compound 13 ( Figure 4) proved a maximum activity among others. Those studies opened up the possibility of development of novel 9-Anilino acridines to inhibit the topoisomerase-II and β-Haematin formation to mitigate the resistance of malarial parasites towards the conventional anti-malarial agents (Saranya et al., 2003). Condensation reaction carried out between quinolone and acridine scaffolds to synthesise Acridine-Quinoline hybrids and performed the molecular docking studies with the binding site of PfDHFR-TS enzyme with the aid of Glide V5.6.5 best compounds selected from docking studies to carry out the In vitro evaluation of anti malarial activity against resistant strains of plasmodium falciparum by micro dilution technique. Compound K 3 ( Figure 5) was proved an effective therapeutic agent than standard drugs such as quinine and chloroquine (Kalpna et al., 2016).

Anti-viral Activity of Acridine Derivatives
The anti-HIV activity was observed with BRACO-19, a trisubstituted acridine derivative. An anti-HIV activity may be due to its ability to bind with dynamic G-quadruplex region of DNA. Inhibition of promoter activity and anti-viral effects have been observed when BRACO-19 stabilised this region. The anti-viral mechanism of action of BRACO-19 was characterised by analysing its activity towards a broad range of HIV-1 strains, host cells and infection modes. Nevirapine used as standard. Anti viral assays were carried out in HIV-1 infected MT-4 -LTR -eGFP and MTT based anti viral assay in HIV infected MT-4 cell line. In the irst method, RPMI 1640 medium supplemented with 10% fetal bovine serum,0.1% sodium bicarbonate,20 µg/ml gentamycin.
MT-4 -LTR -eGFP is infected with HIV-I(III B ) at a multiplicity of infection of 0.5 and incubated at 37 • C after an hour the cells were washed and seeded in the presence of serial dilutions of BRACO-19 in a 96 well plate. Flow cytometric analysis was performed to determine the Egfp expression to measure HIV-1 production. The second method was performed by tetrazolium based colourimetric assay. In which MT-4 cells were seeded in the HIV-I(III B ) virus stock at 100-300 CCID 50 in the presence of serial dilutions of BRACO-19. Cell viability measured ive days after infection. Sample absorbance was measured in two wavelengths (540 and 690nm) and the median absorbance of 3 wells was calculated, anti viral assay performed in HIV-I infected peripheral blood mono nuclear cells. In which the concentration required to produce 50% inhibition of HIV-1 infection-viral binding assay performed by incubation of stock dilution of HIV-I cells with a serial dilution of BRACO-19. The amount of P24 antigen was measured. Virucidal assay performed by HIV-I incubated with various concentrations of BRACO-19 and the viral infectivity was measured after ive days. It was the irst time the anti viral activity of BRACO-19 evaluated through G-Quadruplex mediated mechanism of action (Perrone et al., 2014).
Guanine rich quadruplexes are targeted by Braco-19 for its anti viral activity against HSV.HSV-1 genome shows multiple clusters of repeated sequences that form very stable G quadruplexes. Virus production was inhibited by the treatment with G quadruplex ligand Braco-19 and the intra cellular DNA in infected cells was decreased. Braco-19 exhibited a signi icant anti viral activity at 1µm, and the activity increased up to 70% at 25 µm. This work suggests the G quadruplex ligands may be considered as a new target for the treatment of herpetic infections (Artusi et al., 2015).

Antibacterial Activity of Acridine Derivatives
In this study, benzotriazole substituted acridine analogues were synthesised and investigated the antibacterial activity. The 9-substituted acridine derivatives were synthesised by the reaction between 9-Chloro acridines with O-phenylene diamine.
Those compounds were inally condensed with benzotriazole to form benzotriazole substituted acridine derivatives.
The reaction was monitored by TLC plates using chloroform: methanol(9:1) con irmed by visualisation of spots by iodine vapours. The synthesised compounds were characterised by IR and 1 H NMR spectral studies. The antibacterial activities of synthesised compounds investigated against gram-positive (S.aureas and B.subtlis) and gram-negative (E.coli) bacterial strains by cup plate method. The synthesised compounds were diluted at the concentrations of 100,500,1000,5000,10000 µg ml −1 . Standard drug (Ampicillin) is diluted to 100 µg ml −1 . Previously inoculated suspension carefully poured into the Petri dishes containing medium. The uniform quantity of the test solutions and standard solution were applied carefully on the surface of the solid medium in cavities prepared in agar, incubated for about 18 hours at 32-35 • C. Zone of inhibition was accurately measured. The benzotriazole substituted compounds shown signi icant anti bacterial activity compared with standard drug ampicillin. It was cleared from the results of the benzotriazole substitution at 9 th position of acridine will give rise to potent antibacterial agents (Singh et al., 2011).
Rivanol is a substituted di amino acridine it has been already used to induce abortion in the midtrimester, and it was also found that rivanol can bind intensely to DNA eventually leads to the development of mutation. In this study, rivanol is screened for bacterial mutagenic activity against E.coli K 12 Strains which has the genetic markers supF, supE, gal and hsdR. Luria broth culture used to inoculate the strains and rivanol was added at different concentrations and incubated at 37 • C to stationary phase. A uniform inoculum about 10 7 cells/ml. The concentrations of viable cells were determined by plating dilutions of each culture of Luria broth agar, and plating dilutions of each culture determined the concentrations of up mutants on minimal glucose-containing agar. Rivanol treated samples had fewer.

Viable cells than untreated controls.
Rivanol did not increase the frequency of upp mutants at the concentrations below 100µg/ml, but the mutant frequency was increased up to 8 fold at the Concentrations 100µg/ml. It shows that rivanol exhibits dose-dependent mutagenic activity. Rivanol bound to bacterial DNA 2-5 times greater than acridine orange and pro lavine. It reveals that the selective bacterial toxicity achieved when the acridine nucleus is 6,9-di amino-substituted analogue (Miriyam and C, 1983).

Anti Tubercular Activity of Acridine Derivatives
Several analogues of 2-methoxy-9-Substituted acridine and 6-chloro-2-methoxy-9-substituted acridine were synthesised. In which the chlorobenzoic acid was treated with methoxy aniline in the presence of K 2 CO 3 /Cu/DMF and the resultant compound was react with pocl 3 led to the formation of substituted chloro methoxy acridine, which was again reacted with sulphanilamide and 4-amino acetophenone and produced the derivatives of the same. The synthesised compounds were screened for their anti tubercular activity by microplate alamar blue assay method against M. Tuberculosis H 37 Rv and Rifampicin was used as positive drug control. It was concluded that the introduction of chlorine atom brings a signi icant contribution to acridine analogues to exhibit the optimum antitubercular activity (Aly and Abadi, 2004). The synthesis of twelve acridine and polycyclic acridine molecules carried out by Friedlander reaction mechanism. In which one-pot reactions conducted between 2-amino-5-chloro or 5-nitro benzophenones and a variety of cyclanones and indanones in the microwave oven. The synthesised products are subjected to the evaluation of antitubercular activity against M.Tuberculosis H 37 Rv. Among the synthesised compounds cyclopenta acridine derivatives proved an antitubercular activity almost similar to that of rifampin. Those molecules might be lead molecules in future (Muscia et al., 2014).
Synthesised compounds puri ied by column chromatography by using an eluent ethyl aceto acetate and cyclohexane (2:8). 1 H NMR and IR spectroscopy characterise the synthesised compounds. The synthesised compounds were investigated their anti fungal activity against C.albicians &A. Niger and anti bacterial activity against B.subtilis and E.coli by the cup-plate method. DMSO is used as control and Ampicillin(100µg/ml) &ketoconazole(100µg/ml) used as standards for anti-bacterial and anti-fungal activities, respectively. MIC values are calculated after the incubation of 24 hours and 48 hours for bacteria and fungi respectively and given in the Table 1 (Ranganath, 2017).
New anti microbial compounds containing more than one pharmacophore were synthesised. In this experiment, an already established acridine molecule ethacridine was connected with 2-amino substituted thiazolidinones and the pharmacophoric amino or aldehyde groups created by an appropriate synthetic scheme. The synthesised compounds are charactierized by IR and NMR spectroscopy and studied their antibacterial and anti-fungal activities. Antibacterial and anti-fungal susceptibility tests were performed in vitro with standard bacterial cultures of S.Aureas, E.coli, K.Pneumoniae, B.subtilis, and standard fungal cultures of C.albicians, C.Glabrata, C.Krusei, C.Kefyr, C.tropicalis, C.Parapsilosis respectively by serial broth dilution technique. The experimental results showed that the synthesised compounds exhibit bacteriostatic and fungistatic actions at low concentrations but bactericidal and fungicidal actions at high concentrations. The compounds 2a-c ( Figure 6,  Figure 7, Figure 8) showed greater antibacterial and anti-fungal activities than ethacridine (Petrikaite et al., 2007).

Antitumor Activity of Acridine Derivatives
A new class of Thiazacridine analogues were synthesised by a combination of acridine and thiazolidine nucleus and investigated their cytotoxic activity against human colon carcinoma HCT -8 cells. In which four compounds synthesised named as Ac-4, Ac-7, Ac-10, Ac-23 (Figure 9). The synthesised compounds were proved to reduce the proliferation of HCT -8 cells in a concentration and time-dependent manner. A marked increase in intra nucleosomal DNA fragmentation was achieved without altering the membrane integrity. Hematoxylin-eosin and acridine orange/ethidium bromide dyes were used to stain HCT -8 cells treated with synthesised compounds to observe the morphological changes under a light microscope. Cells were pelleted and resuspended with 25µl of PBS then mixed with 1µl of acridine orange/ethidium bromide solution and the morphological changes were observed under a luorescence microscope.
The integrity of the cell membrane was assessed by using the exclusion of propidium iodide and low cytometric principles were used to determine the cell luorescence. Cell cycle distribution was determined by harvested the cells in a solution of citrate 0.1%, Triton X-100 0.1% and propidium iodide 50 µg/ml and the cell luorescence was determined by low cytometry. The mitochondrial transmembrane potential was measured by rhodamine 123 dye method. In which the cells were washed with PBS and incubated with rhodamine 123 at 37 • C and the cell luorescence was measured by low cytometry. Phosphatidyl serine externalisation was determined by washed the cells with cold PBS and resuspended in 135µl of PBS and with 5 µl of 7-amino actinomycin D (7AAd) and 10 µl of annexin V-PE and incubated at room temperature for 20 minutes and the cell activity measured by low cytometry. Caspase 3/7 activity was analysed by the cells incubated with luorescently labelled inhibitor and suspended with wash buffer after the incubation of prescribed time duration then centrifuged. The pellet was resuspended in the solution of propidium iodide and wash buffer then immediately analysed by low cytometry. Drop test assay was performed to determine the sensitivity of mutant S.Cerevisiae with defective topoisomerases. DNA relaxation assay was performed Topo I drug screening kit. The isolated lymphocytes determined genotoxicity in human lymphocytes were mixed with RPMI 1640 supplemented with 20% foetal bovine serum, phytohemagglutinin, two mM glutamine,100U/ml penicillin and 100 µg/ml of streptomycin at 37 • C with 5% CO 2 . Finally, the cell viability was determined by trypan blue assay method-alkaline (PH <13) comet assay was performed by using single-cell gel electrophoresis. The damage index (DI) was calculated by migration length and amount of DNA in the tail. Chromosome aberration assay was performed. Doxorubicin was used as the positive control. Synthesised compounds added at prescribed concentrations to the culture after the incubation cells were harvested and treated with 0.075M KCl at 37 • C for 20 minutes then stained with 3% Giemsa solution and focused under a light microscope to determine the frequency of CAs and the mitotic index. Telomerase inhibition assay was performed by determining the length of telomere using luorescence in situ hybridisation with probes to telomeric sequences. The images were processed using the TFL-TELO software (Barros et al., 2013).

The
anti-telomerase activity of 6,phenylamino]-3,6-bis(3pyrrolodinopropionamido) acridine) was directed the researchers to evaluate the anti-cancer activity. Since the telomerase complex is responsible for telomere maintenance, so it was believed that anti telomerase agents could exhibit potent anti-cancer activity. In this investigation a small molecule with anti telomerase activity designed by molecular modelling in a supercomputer to achieve signi icant interaction with G-Quadruplex region of DNA to form telomeric DNA to produce complete inhibition of the activity of telomerase.
One another surprising fact found in these studies is BRACO-19 did not produce non-speci ic acute cytotoxicity at same concentrations to those needed to inhibit an entire activity of telomerase. When BRACO-19 tested against 21NT human breast cancer cells results in a signi icant reduction of cell growth after only 15 days. The reduction of intracellular telomerase activity was indicated by a marked increase in the number of β-Galactosidase positive staining cells. In vivo anti-cancer activity is evaluated by intraperitoneal administration of 2mg/kg body weight of BRACO-19 to the mice having advanced stage A431 human vulval carcinoma previously treated with paclitaxelinduced antitumour effect and compared the observations with the group treated with paclitaxel alone. From these studies, it was concluded that BRACO-19 irst choice of the second generation of G-Quadruplex mediated telomerase/telomere interactive compounds (Sharon et al., 2002).
Since telomeric integrity is an essential factor for replication of cancer cells, so it is considered as a target for the G-quadruplex-stabilising drug 3,11-di luoro-6,8,13-trimethyl-8H-quino[4,3,2kl]acridinium methosulfate in this study. It was proved a senescent-like growth arrest in MCF-7 breast cancer cells, within 14 to 17 days, and a reduction in telomere length (from 5.2 kilobases (kb) to 4.7 and 4.3 kb after 17 days of treatment at 0.5 and 1 µM, respectively). This compound does not exhibit cytotoxicity at therapeutic concentrations (doses < 1 µM over a 14-day exposure), and it was found to be compatible even with longterm treatment.MCF-7 cells were ten times more sensitive to synthesised compounds compared with wild-type (wt) hTERT-expressing, vectortransfected control cells (longer TRF-length 5.2 kb; IC 50 2 µM) in the 5 day SRB assay. This relationship was validated in a section of 36 human tumour xenografts grown in vitro positively correlated between telomere length and growth-inhibitory potency of RHPS4 (15-day clonogenic assay, r = 0.75). Those observations are constant with loss of the protective capping status of telomeres mediated by RHPS4 G-quadruplex-stabilization, thus leading to the greater susceptibility of cells with shorter telomeres. Combination studies were carried out with paclitaxel (Taxol), doxorubicin (Adriamycin), and the experimental therapeutic agent 17-(allylamino)-17-dimethoxy geldanamycin, which inhibits the 90-kDa heat shock protein, conferred enhanced sensitivity in RHPS4 treated MCF-7 cells. In contrast, the DNA-interactive temozolomide and cisplatin antagonised the action of RHPS4. Experimental results suggested the combination of certain classes of existing anti-cancer agents with this synthesised compound would be synergistic (Cookson et al., 2005).

Anti In lammatory Activity of Acridine Derivatives
Anti-in lammatory, analgesic and kinase inhibition activities are evaluated with novel acridine derivatives. Those analogues are synthesised by condensation of 9-chloro-2,4-(un) substituted acridines with sulphanilamide derivatives such as sulphadiazine, sulphathiazole and sulfacetamide (3a-3h) and 3-Aryl -4-phenyl -2-imino-4-thiazolines (5a-5h). The condensation products were puri ied by chromatography or crystallisation. Anti-in lammatory activity was evaluated by using carrageenaninduced paw oedema in which albino rat model was used.0.1 ml of 1% solution Carrageenan was used as an irritant to develop oedema by administered into planter aponeurosis. The volume of the oedema was measured before and after the administration of solutions of standard drug and our synthesised analogues. The analgesic activity was measured by the writhing assay method in which the aqueous solution of phenyl quinone was administered intraperitoneally to the animal groups. The number of writhes recorded for 20 minutes, and the same was repeated after the administration of our test solutions containing desired concentrations of synthesised substances and standard. Compounds 5a,5c,5g ( Figure 10 & Table 2) showed excellent anti-in lammatory activity, and compounds 3e (Figure 11), 5m ( Figure 12) showed a signi icant analgesic activity (Sham et al., 2004).
Acridine derivatives (9-Anlino &9-Phenoxy) were synthesised and subjected to the evaluation of anti-in lammatory activity studies on the inhibitory effect of the suppression of activation of a mast cell, neutrophils and macrophages. Synthesised compounds showed a potent anti-in lammatory activity than reference standard and also exhibited a potent inhibitory effect on the secretion of lysosomal enzyme and β-glucuronidase from neutrophil. Some compounds also inhibit TNF α production macrophage-like cell line Raw 264.7. The synthesised compounds were found to be a potent inhibitor of TNF α production in microglial cell lines 94, and it was also observed that there was no signi icant cytotoxicity in those acridine derivatives (Chen et al., 2002).

Anti Leishmanial Activity of Acridine Derivatives
A quantitative structure-activity relationship has carried out with acridine derivatives for anti leishmanial activity. In this study molecular structures of totally 60 molecules of differently substituted acridines involved. Multiple linear regression and arti icial neural network methods used to study, interpret and predict the activity of the newly designed molecules.
The used descriptors are igured with gaussian 03, ACD/Chemsketch, Marvin sketch and chem of ice programs. The QSAR models established were validated based on principles framed by OECD. The descriptors are highly correlated with the activity were selected by principal component analysis (PCA). The dataset was divided into training sets and test sets by univariate partitioning (UP) method. The correlation coef icient calculated by multiple linear regression (MLR) equations. The correlation coef icient values were found to be 0.850, and 0.814 for anti leishmanial activities against promastigotes and amastigotes forms parasites respectively and validated by both internal and external validation methods and the statistical quality of QSAR models determined. The correlation coef icient of the descriptors acquired from the MLR in the arti icial neural network was found to be 0.933 and 0.918 with 7-3-1 and 6-3-1 for antileishmanial activities against promastigotes and amastigotes forms of parasites, respectively (Chtita et al., 2016).
A series of 9-anilino acridines were synthesised and screened for the anti leishmanial activity against both the promastigote and amastigote forms of a parasite. It was assumed that anti leishmanial activity is due to the Topoisomerase-II inhibitory activity of substituted 9-anilino acridines. In this study 1, NH-hexyl compound prepared and con irmed it's activity and toxicity to mammalian cells also determined by using human leukaemia cell line. Then it was considered as Lead. Substitution pattern of 3,6di(di methyl amino) group dramatically increases the antileishmanial activity without increasing the toxicity towards mammalian cells. The substitution of 2-OMe and 6-Cl also brought potent antileishmanial activity. Substitution of N(R) 2 At the acridine molecule leads to bene icial antileishmanial compound This study was revealed that highly electrondonating lipophilic substitutions at the position -1 of 9-Anilino acridines make a potent antileishmanial compound (Gamage et al., 1997).

CONCLUSION
Bacterial, parasitic and viral infections are still a challenging task for physicians, of course, the acridine usage is limited due to some side effects and tumour resistance even though so many potent drug candidates can be derived from acridine nucleus with expected safety pro ile. It can be achieved by molecular modi ication; for example, acronycine the moderately potent and low watersoluble compound can be improved by molecular modi ication leads to the effective and highly watersoluble compound. Some of the acridine derivatives shown multiple pharmacological activities, for example, quinacrine was invented for the treatment of malaria but also exhibited remarkable anti-cancer activity which will give the useful information of the pharmacophore for the various targets. The strong cationic region of acridine dyes was found to be essential for their anti-microbial activity. The most important limiting factor governing the anti microbial activity of acridines is the degree of ionisation. Tacrne is an anti-Alzheimer drug, but it's usage become limited so the structure may be modi ied to produce new agent with improved ef icacy and less toxicity. The drug repurposing studies also provide some useful information to produce novel therapeutic agents. This study reveals that the acridine/acridone moiety can provide so many lead molecules which can be modi ied further to obtain new, safe and effective drug candidate for bacterial, viral, fungal, parasitic and malarial infections. Our overall aim is to motivate the researchers to focus on the above mentioned key points to generate a safe and potent molecule from acridine to manage the challenging tasks of various diseases.